SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+3.76%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$151M
AUM Growth
+$151M
(+18%)
Cap. Flow
+$26.9M
Cap. Flow
% of AUM
17.79%
Top 10 Holdings %
Top 10 Hldgs %
42.26%
Holding
109
New
25
Increased
23
Reduced
25
Closed
15
Top Buys
| 1 |
MBX
MBX Biosciences, Inc. Common Stock
MBX
|
$2.19M |
| 2 |
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
|
$2.16M |
| 3 |
Replimune Group
REPL
|
$2.15M |
| 4 |
Oric Pharmaceuticals
ORIC
|
$2.15M |
| 5 |
Solid Biosciences
SLDB
|
$2.05M |
Top Sells
| 1 |
Medtronic
MDT
|
$2.14M |
| 2 |
Gilead Sciences
GILD
|
$1.37M |
| 3 |
Tenet Healthcare
THC
|
$1.21M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$1.12M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$994K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
enGene Holdings
ENGN
$236M
| – | – |
-11,700
| Closed | -$52.4K |
|
102
Icon
ICLR
$13.8B
| – | – |
-4,000
| Closed | -$700K |
|
|
103
Medtronic
MDT
$119B
| – | – |
-23,850
| Closed | -$2.14M |
|
104
Novo Nordisk
NVO
$251B
| – | – |
-2,850
| Closed | -$198K |
|
105
Phreesia
PHR
$1.88B
| – | – |
-34,000
| Closed | -$869K |
|
106
Rocket Pharmaceuticals
RCKT
$354M
| – | – |
-44,383
| Closed | -$296K |
|
107
iShares 0-3 Month Treasury Bond ETF
SGOV
$56.1B
| – | – |
-3,589
| Closed | -$361K |
|
|
SWTX
108
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-25,325
| Closed | -$1.12M |
|
|
109
Tenet Healthcare
THC
$16.3B
| – | – |
-9,000
| Closed | -$1.21M |
|